Ivica Kristić1, Mislav Vrsalovic2,3, Nikola Crnčević1, Frane Runjić1, Vesna Čapkun4, Ozren Polašek5, Andrija Matetic1. 1. Department of Cardiology, University Hospital of Split, Split, Croatia. 2. Department of Cardiology, Sestre Milosrdnice University Hospital Center, Vinogradska cesta 29, 10000, Zagreb, Croatia. mislav.vrsalovic@gmail.com. 3. University of Zagreb School of Medicine, Zagreb, Croatia. mislav.vrsalovic@gmail.com. 4. University Department of Health Studies, University of Split, Split, Croatia. 5. Department of Public Health, School of Medicine, University of Split, Split, Croatia.
Abstract
BACKGROUND: Risk stratification of patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) is an important clinical method, but long-term studies on patients subjected to all-treatment strategies are lacking. Therefore, the aim was to compare several established risk scores in the all-treatment NSTE-ACS cohort during long-term follow-up. METHODS: Consecutive patients (n = 276) with NSTE-ACS undergoing coronary angiography were recruited between September 2012 and May 2015. Six risk scores for all patients were calculated, namely GRACE 2.0, ACEF, SYNTAX, Clinical SYNTAX, SYNTAX II PCI and SYNTAX II CABG. The primary end-point was Major Adverse Cardiovascular Events (MACE) which was a composite of cardiac death, nonfatal myocardial infarction, ischemic stroke or urgent coronary revascularization. RESULTS: During a median follow-up of 33 months, 64 MACE outcomes were recorded (23.2%). There was no difference between risk score categories, except in the highest risk group of ACEF and SYNTAX II PCI scores which exhibited significantly more MACE (51.6%, N = 33 and 45.3%, N = 29, P = 0.024, respectively). In the multivariate Cox regression analysis of individual variables, only age and atrial fibrillation were significant predictors for MACE (HR 1.03, 95% CI 1.00-1.05, P = 0.023 and HR 2.02, 95% CI 1.04-3.89, P = 0.037, respectively). Furthermore, multivariate analysis of the risk scores showed significant prediction of MACE only with ACEF score (HR 2.16, 95% CI 1.36-3.44, P = 0.001). The overall performance of GRACE, SYNTAX, Clinical SYNTAX and SYNTAX II CABG was poor with AUC values of 0.596, 0.507, 0.530 and 0.582, respectively, while ACEF and SYNTAX II PCI showed the best absolute AUC values for MACE (0.630 and 0.626, respectively). CONCLUSIONS: ACEF risk score showed better discrimination than other risk scores in NSTE-ACS patients undergoing all-treatment strategies over long-term follow-up and it could represent a fast and user-friendly tool to stratify NSTE-ACS patients.
BACKGROUND: Risk stratification of patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) is an important clinical method, but long-term studies on patients subjected to all-treatment strategies are lacking. Therefore, the aim was to compare several established risk scores in the all-treatment NSTE-ACS cohort during long-term follow-up. METHODS: Consecutive patients (n = 276) with NSTE-ACS undergoing coronary angiography were recruited between September 2012 and May 2015. Six risk scores for all patients were calculated, namely GRACE 2.0, ACEF, SYNTAX, Clinical SYNTAX, SYNTAX II PCI and SYNTAX II CABG. The primary end-point was Major Adverse Cardiovascular Events (MACE) which was a composite of cardiac death, nonfatal myocardial infarction, ischemic stroke or urgent coronary revascularization. RESULTS: During a median follow-up of 33 months, 64 MACE outcomes were recorded (23.2%). There was no difference between risk score categories, except in the highest risk group of ACEF and SYNTAX II PCI scores which exhibited significantly more MACE (51.6%, N = 33 and 45.3%, N = 29, P = 0.024, respectively). In the multivariate Cox regression analysis of individual variables, only age and atrial fibrillation were significant predictors for MACE (HR 1.03, 95% CI 1.00-1.05, P = 0.023 and HR 2.02, 95% CI 1.04-3.89, P = 0.037, respectively). Furthermore, multivariate analysis of the risk scores showed significant prediction of MACE only with ACEF score (HR 2.16, 95% CI 1.36-3.44, P = 0.001). The overall performance of GRACE, SYNTAX, Clinical SYNTAX and SYNTAX II CABG was poor with AUC values of 0.596, 0.507, 0.530 and 0.582, respectively, while ACEF and SYNTAX II PCI showed the best absolute AUC values for MACE (0.630 and 0.626, respectively). CONCLUSIONS:ACEF risk score showed better discrimination than other risk scores in NSTE-ACS patients undergoing all-treatment strategies over long-term follow-up and it could represent a fast and user-friendly tool to stratify NSTE-ACS patients.
Authors: Joanna J Wykrzykowska; Scot Garg; Yoshinobu Onuma; Ton de Vries; Dick Goedhart; Marie-Angele Morel; Gerrit-Anne van Es; Pawel Buszman; Axel Linke; Thomas Ischinger; Volker Klauss; Roberto Corti; Franz Eberli; William Wijns; Marie-Claude Morice; Carlo di Mario; Robert Jan van Geuns; Peter Juni; Stephan Windecker; Patrick W Serruys Journal: Circ Cardiovasc Interv Date: 2011-01-04 Impact factor: 6.546
Authors: Barbara E Stähli; Manfred B Wischnewsky; Philipp Jakob; Roland Klingenberg; Slayman Obeid; Dik Heg; Lorenz Räber; Stephan Windecker; Marco Roffi; François Mach; Baris Gencer; David Nanchen; Peter Jüni; Ulf Landmesser; Christian M Matter; Thomas F Lüscher; Willibald Maier Journal: Int J Cardiol Date: 2018-06-01 Impact factor: 4.164
Authors: Vasim Farooq; David van Klaveren; Ewout W Steyerberg; Emanuele Meliga; Yvonne Vergouwe; Alaide Chieffo; Arie Pieter Kappetein; Antonio Colombo; David R Holmes; Michael Mack; Ted Feldman; Marie-Claude Morice; Elisabeth Ståhle; Yoshinobu Onuma; Marie-angèle Morel; Hector M Garcia-Garcia; Gerrit Anne van Es; Keith D Dawkins; Friedrich W Mohr; Patrick W Serruys Journal: Lancet Date: 2013-02-23 Impact factor: 79.321
Authors: Ply Chichareon; Rodrigo Modolo; David van Klaveren; Kuniaki Takahashi; Norihiro Kogame; Chun-Chin Chang; Yuki Katagiri; Mariusz Tomaniak; Taku Asano; Ernest Spitzer; Pawel Buszman; Janusz Prokopczuk; Farzin Fath-Ordoubadi; Ian Buysschaert; Richard Anderson; Keith G Oldroyd; Bela Merkely; Scot Garg; Joanna J Wykrzykowska; Jan J Piek; Peter Jüni; Christian Hamm; Philippe Gabriel Steg; Marco Valgimigli; Pascal Vranckx; Stephan Windecker; Yoshinobu Onuma; Patrick W Serruys Journal: Int J Cardiol Date: 2019-02-20 Impact factor: 4.164
Authors: Tullio Palmerini; Adriano Caixeta; Philippe Genereux; Ecaterina Cristea; Alexandra Lansky; Roxana Mehran; George Dangas; Dana Lazar; Rachel Sanchez; Martin Fahy; Ke Xu; Gregg W Stone Journal: Am Heart J Date: 2012-03 Impact factor: 4.749